BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 31313045)

  • 1. Thoracic Duct Resection During Esophagectomy Does Not Contribute to Improved Prognosis in Esophageal Squamous Cell Carcinoma: A Propensity Score Matched-Cohort Study.
    Oshikiri T; Takiguchi G; Miura S; Goto H; Otsubo D; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Nakamura T; Suzuki S; Kakeji Y
    Ann Surg Oncol; 2019 Nov; 26(12):4053-4061. PubMed ID: 31313045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thoracic Duct Resection Has a Favorable Impact on Prognosis by Preventing Hematogenous Spread of Esophageal Cancer Cells: A Multi-institutional Analysis of 2269 Patients.
    Tanaka K; Yamasaki M; Sugimura K; Shiraishi O; Motoori M; Hamakawa T; Takeno A; Yamashita K; Makino T; Kimura Y; Miyata H; Hirao M; Eguchi H; Yasuda T; Yano M; Doki Y
    Ann Surg Oncol; 2021 Aug; 28(8):4402-4410. PubMed ID: 33861403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally Invasive Esophagectomy with Thoracic Duct Resection Post Neoadjuvant Chemoradiotherapy for Carcinoma Esophagus-Impact on Lymph Node Yield and Hemodynamic Parameters.
    Anand S; Kalayarasan R; Chandrasekar S; Gnanasekaran S; Pottakkat B
    J Gastrointest Cancer; 2019 Jun; 50(2):230-235. PubMed ID: 29344808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Thoracic Duct Resection Necessary for Esophageal Squamous Cell Carcinoma Patients Treated with Neoadjuvant Chemoradiotherapy? A Propensity-Matched Analysis Based on the Comprehensive Registry of Esophageal Cancer in Japan.
    Oshikiri T; Numasaki H; Oguma J; Toh Y; Watanabe M; Muto M; Kakeji Y; Doki Y
    Ann Surg Oncol; 2023 May; 30(5):2691-2698. PubMed ID: 36529778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of Patients with Esophageal Carcinoma After Routine Thoracic Duct Resection: A Propensity-matched Analysis of 12,237 Patients Based on the Comprehensive Registry of Esophageal Cancer in Japan.
    Oshikiri T; Numasaki H; Oguma J; Toh Y; Watanabe M; Muto M; Kakeji Y; Doki Y
    Ann Surg; 2023 May; 277(5):e1018-e1025. PubMed ID: 34913902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of robotic-assisted versus thoraco-laparoscopic McKeown esophagectomy for esophageal cancer: a propensity score-matched study.
    Xu Y; Li XK; Cong ZZ; Zhou H; Wu WJ; Qiang Y; Yi J; Shen Y
    Dis Esophagus; 2021 Sep; 34(9):. PubMed ID: 33150401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic thoracic duct ligation is associated with poor prognosis and regional lymph node relapse in esophageal squamous cell carcinoma.
    Chen JY; Liu QW; Zhang SS; Li JB; Yang H; Wen J; Fu JH
    J Surg Oncol; 2020 Aug; 122(2):336-343. PubMed ID: 32410255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Resection of the Thoracic Duct and Surrounding Lymph Nodes on Short- and Long-Term and Nutritional Outcomes After Esophagectomy for Esophageal Cancer.
    Yoshida N; Nagai Y; Baba Y; Miyamoto Y; Iwagami S; Iwatsuki M; Hiyoshi Y; Eto K; Ishimoto T; Kiyozumi Y; Nomoto D; Akiyama T; Imamura Y; Watanabe M; Baba H
    Ann Surg Oncol; 2019 Jun; 26(6):1893-1900. PubMed ID: 30863941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Cervical Lymph Node Dissection in Thoracoscopic Esophagectomy for Esophageal Cancer Increases Postoperative Complications and Does Not Improve Survival.
    Koterazawa Y; Oshikiri T; Takiguchi G; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Matsuda T; Nakamura T; Fujino Y; Tominaga M; Suzuki S; Kakeji Y
    Ann Surg Oncol; 2019 Sep; 26(9):2899-2904. PubMed ID: 31187365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct.
    Matsuda S; Takeuchi H; Kawakubo H; Shimada A; Fukuda K; Nakamura R; Takahashi T; Wada N; Kameyama K; Kitagawa Y
    Medicine (Baltimore); 2016 Jun; 95(24):e3839. PubMed ID: 27310961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimally invasive oesophagectomy with extended lymph node dissection and thoracic duct resection for early-stage oesophageal squamous cell carcinoma.
    Matsuda S; Kawakubo H; Takeuchi H; Hayashi M; Mayanagi S; Takemura R; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
    Br J Surg; 2020 May; 107(6):705-711. PubMed ID: 32077101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement Effect of Upper Mediastinal Lymphadenectomy During Minimally Invasive Esophagectomy on the Prognosis in Squamous Cell Carcinoma: Efficacy Index and Propensity Score Matching Analyses.
    Oshikiri T; Goto H; Kato T; Hasegawa H; Kanaji S; Yamashita K; Fujino Y; Tominaga M; Matsuda T; Kakeji Y
    J Am Coll Surg; 2023 Nov; 237(5):762-770. PubMed ID: 37366544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph Node Evaluation in Robot-Assisted Versus Video-Assisted Thoracoscopic Esophagectomy for Esophageal Squamous Cell Carcinoma: A Propensity-Matched Analysis.
    Chao YK; Hsieh MJ; Liu YH; Liu HP
    World J Surg; 2018 Feb; 42(2):590-598. PubMed ID: 28801820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and mid-term outcomes of robotic versus thoraco-laparoscopic McKeown esophagectomy for squamous cell esophageal cancer: a propensity score-matched study.
    Yang Y; Zhang X; Li B; Hua R; Yang Y; He Y; Ye B; Guo X; Sun Y; Li Z
    Dis Esophagus; 2020 Jun; 33(6):. PubMed ID: 31608939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended Right Thoracic Approach Compared With Limited Left Thoracic Approach for Patients With Middle and Lower Esophageal Squamous Cell Carcinoma: Three-year Survival of a Prospective, Randomized, Open-label Trial.
    Li B; Hu H; Zhang Y; Zhang J; Miao L; Ma L; Luo X; Zhang Y; Ye T; Li H; Zhou J; Li Y; Shen L; Zhao K; Fan M; Zhu Z; Wang J; Xu J; Deng Y; Lu Q; Jia H; Cheng X; Li H; Zhang Y; Li C; Pan Y; Liu S; Hu H; Shao L; Sun Y; Xiang J; Chen H
    Ann Surg; 2018 May; 267(5):826-832. PubMed ID: 28448385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival risk prediction model for patients with pT
    Qi Z; Hu Y; Qiu R; Li J; Li Y; He M; Wang Y
    J Cardiothorac Surg; 2021 May; 16(1):121. PubMed ID: 33933129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
    Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy comparison between two-field and three-field lymphadenectomy for thoracic esophageal squamous cell carcinoma].
    Lin D; Ye T; Ma L; Shao L; Song Z; Jiang S; Xiang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):990-994. PubMed ID: 27680065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node dissection and recurrent laryngeal nerve protection in minimally invasive esophagectomy.
    Wang Z; Mao Y; Gao S; Li Y; Tan L; Daiko H; Liu S; Chen C; Koyanagi K; He J
    Ann N Y Acad Sci; 2020 Dec; 1481(1):20-29. PubMed ID: 32671860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal invasive versus open esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant treatments.
    Chen D; Wang W; Mo J; Ren Q; Miao H; Chen Y; Wen Z
    BMC Cancer; 2021 Feb; 21(1):145. PubMed ID: 33563244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.